Canadian officials are mulling an attack on US pharma, says Ottawa lawyer
Amir Attaran, a biomedical scientist and University of Ottawa law professor, … In 1969, the Patent Act was amended to allow firms to import the active …
In: PATENT NEWS
Amir Attaran, a biomedical scientist and University of Ottawa law professor, … In 1969, the Patent Act was amended to allow firms to import the active …
In: PATENT NEWS
The plan would target valuable U.S. patents, granting Canada’s generic pharmaceutical firms the right to copy, sell and potentially export American …
In: PATENT NEWS
The Trademark Act, like the Patent Act, provides for injunctions “according to principles of equity.” How is Congress to stop Supreme Court precedent …
In: TRADEMARK NEWS
Creative trademark strategies are essential for brands venturing into newly-legalised US marijuana markets World Trademark Review (blog) Full coverage
In: PATENT NEWS
BeyondSpring Strengthens Intellectual Property Portfolio with Newly Granted US Patent for Plinabulin Nasdaq Full coverage
In: PATENT NEWS
Ulthera Appeals PTAB Decision Upholding Skin Care Patent Law360 Full coverage
In: PATENT NEWS
Law360 (September 18, 2018, 8:39 PM EDT) — Medical device company Ulthera Inc. asked the Federal Circuit on Tuesday to rehear its challenge to a …
In: PATENT NEWS
Earlier this month, the U.S. Patent and Trademark Office asked the justices to overturn a December ruling by the Federal Circuit that the Lanham Act’s …
In: PATENT NEWS
Fed. Circ. Ruling Takes ‘Blocking Patents’ To New Places Law360 Full coverage
In: PATENT NEWS
The general idea behind the blocking patent doctrine is that if a company … “Had the court’s approach to the law of obviousness been in effect when …
Designed by Industrial Action
Copyright © 2025 OPUS IP Limited. All Rights Reserved
OPUS IP Limited: COMPANY & OTHER LEGAL INFORMATION